DOCSLIB.ORG

List of Registered Firms Over WCR As Per New Policy of Rly. Board up to 23.3.12

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Registered Firms Over WCR As Per New Policy of Rly. Board up to 23.3.12 List of Registered Firms over WCR as per New Policy of Rly. Board up to 23.3.12 Sr. Name & Address of Firms No. 1 Akum Drugs & Pharmaceuticals Ltd. 304, Mohan Palace, LSC Block-C, Saraswati Vihar, Delhi - 110034 2 M/s. Astra Zeneca Pharma India Limited, P.B.No.2483, Off. Bellary Road, Hebbal, Bangalore -560024 3 Abbott India Limited, 3-4, Corporate Park, Sion Trombay Road, Mumbai-400071) 4 Ajanta Pharma Limited, Ajanta House, Charkop, Kandivli (W), Mumbai-400067 5 Arvind Remedies Limited, New # 190, Poonamallee High Road, Chennai-600084 6 Aventis Pharma Limited, Aventis house, 54/A, Sir Mathuradas Vasanji Road, Andheri (E), Mumbai-400093 7 M/s. Alembic Limited (1) II nd Floor, 4/18, Shashi Building, Asaf Ali Road, New Delhi 110002 (2) Prime Corporate Park, 2nd Floor, Behind ITC, Grand Maratha Sheraton Hotel, Sahar Road, Andheri ( E), Mumbai – 400099 8 Biological E. Limited 18/1 & 3, Azamzbad, Hyderabad-500 020 AP 9 Bengal Chemicals & Pharmaceuticals Ltd. 1149, Napier Town, Near Home Science College Jabalpur-482002 Regd. Office- 6, Ganesh Chunder Avenue, Kolkata-700013 10 Biochem Pharmaceuticals Industries Ltd. Aidun Building, John Crasto Lane, Near Metro Adlabs, Mumbai - 400002 11 Biocon Limited, 20th KM Hosur Road, Electronic City, Banglore-560100 12 Bal Pharma Limited Laxmi Narayan Complex, 5th floor, 10/1, Palace Road, Bangalore-560052 13 Bharat Serum and Vaccine Limited, 17th floor, Hoechst House, Nariman Point, Mumbai-400021 14 Baxter (India) Pvt. Ltd. Trade world B-wing, 3rd floor, Kamla Mills Compound, Senapati Bapat Marg, Lower Parel, Mumbai – 400013 15 Brawn Laboratories Ltd., Old Delhi Stock Exchange Building, 4/4B, Asaf Ali Road, New Delhi-02 16 Bharat Biotec International Ltd. Vamsi Sadan, Plot 265/266, Kamalpuri Colony Phase- II, Hyderabad 500073 17 M/s. Blue Cross Laboratories Limited, Peninsula Chambers, P.O. Box 16360, Lower Parel, Mumbai - 400013 18 Cadila Healthcare Limited, Zydus Tower, Satellite Cross Roads, Ahmedabad-380015 19 Centaur Pharmaceuticals Private Limited, Centaur House, near Grand Hyatt, Vakola, Santacruz (East), Mumbai-400055 20 Cipla Limited, 99,99A,99B, SDA Annex S.D.A Compound, Lasudia Mori, Dewas Naka, A.B. Road, Indore-452008 ( M.P.) 21 Claris Life sciences Limited, Corporate Towers, near Piramal Railway Crossing, Ellisbridge, Ahmedabad-380006 22 Cosme Farma Laboratories Ltd. K.No.136 / 2, Village & P.O Badli, Rithala Road, Above Bank of Baroda, Badli, New Delhi - 110041 23 Dr. Reddy’s Laboratories Limited, 6-3-1192/1/1, White House, Block-III, 5th Floor, Kundanbagh, Begampet, Hydrabad- 500016 24 Eli Lily & Company India Limited Plot No.92, Sector 32, Gurgaon – 122001 Haryana [ Corresp.Add.: Flat No.77, 1st floor, Halwasia Market, Hazratganj, Lucknow -226001.] L. dated 23.4.10 25 Emcure Pharmaceutical Ltd. Survey No. 255/2, Phase -1, Rajiv Gandhi IT Park M.I.D.C.Hinjwadi , Pune -411057 26 Franco Indian Pharmaceuticals Limited B. Jagtap Marg, 20, Dr.E.Moses Road, Mumbai - 400011 27 Fresenius Kabi, Oncology Ltd (Formerly Dabur Pharma Limited ) (1) Echelon Institutional area, Plot No 11, Sector-32, Gurgoan-122001 ( Haryana ) & (2) 22, Site IV, Sahibabad, Ghaziabad-201 010 28 Fresenius Kabi India Pvt. Ltd. 6-E, “Heritage House” Ramabai Ambedkar Road, Pune -411001 29 M/s. Finecure Pharmaceuticals Limited 612 to 615, Anand Mangal Complex-III, Near Parimal Garden, Ahmedabad - 380006 30 Galpha Laboratories Limited, 610, Shah & Nahar, Dr. E.Moses Road, Worli, Mumbai-400018 31 Gland Pharma Limited, 6-3-865/1/2, Flat No.201, Green Land Apartment, Ameerpet, Hydrabad-500016 32 Glenmark Pharmaceuticals Limited, Corporate Enclave, B.D. Sawant Marg, Chakala, Off. Western Express Highway, Andheri (East), Mumbai-400099 33 GlaxoSmithKline Pharmaceuticals Limited, 1st floor 25/3, Yaswant Niwas Road, Indore-452003(MP) 34 Hindustan Latex Ltd. 401-402, 4th Floor, Sabari Samaridhi Building, , Behind Maitri Park, S.T. Stand, Sion- Trombay Road, Chembur, Mumbai – 400071 35 Indian Immunological Limited, Annapurna Agency, 46, Banarji Society, Near Quality Home, Colar Main Road, Bhopal (M.P.) 36 Indoco Remedies Limited, Indoco House, 166 C.S.T. road, Santacruz (East), Mumbai-400098 37 Intas Pharmaceuticals Limited, 2nd Floor, Chinubhai Center, Ashram Road, Ahmedabad-380009 (India) 38 Ipca Laboratories Limited, Post box No. 7688, 142-AB, Kandivli Industrial estate, Kandivli (W) Mumbai-67 39 J.B.Chemicals & Pharmaceuticals Limited, Neelam Center, “B” Wing, 4th floor, Hindcycle Road, Worli, Mumbai-400 030 40 Jindal Photo Ltd. 9, Hanuman Road, New Delhi -110001 41 Khandelwal Laboratories Pvt. Ltd. 79/87,D Lad Path, Kalachouki, Mumbai-400033 42 Karnataka Antibiotics & Pharmaceuticals Limited (A Government of India Enterprises) Dr. Rajkumar Road, 1st Block, Rajajianagar, Banglore-560010 43 Lupin Limited, 159,C.S.T.Road, Kalina, Santacruz (East), Mumbai-400098 44 LG Life Sciences India Pvt. Ltd. L.G. House, AB-3, Safdarjung Enclave, New Delhi- 110029 45 Lyka Labs Limited 101, Shiv Shakti Industrial Estate , Sir M.V. Road, Andheri (E), Mumbai - 400059 46 Morepan Laboratories Ltd. 3rd Floor, Antriksh Bhavan, 22 K.G.Marg, New Delhi - 110001 47 Macleods Pharmaceuticals Limited, Atlanta Arcade, Church Road, Near Leela Hotel, Andheri-Kurla Road, Andheri (East), Mumbai-400059 48 Medley Pharmaceuticals Ltd. Medley House, D-2, MIDC Area,16th Road, Andheri (E), Mumbai- 400093 49 Micro Labs Limited, #27, Race Course Road, Banglore-560001 50 Midas Crae Pharmaceuticals Pvt. Ltd. Papa Industrial Estate, 40, Suren Road, Andheri (E), Mumbai - 400093 51 Merck Limited Pharma Institution, Shivsagar Estate A, Dr.A.B.Road, Worli, Mumbai – 18 Corresp. Add.: A-2 / 202, Printers Apartments, Sector – 13, Rohini, Delhi -110085 52 M/s. Mankind Pharma Ltd. (1) 260, Okhla Industrial Estate-3, New Delhi -110020 6-B, Mohkampur Enclave, Phase-I, Meerut – 250103 53 Novartis India Limited, Pharmaceutical Sector, Sandoz House, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai-400018 / Sudhir Trade Link, 1st Floor, Milandas Manore, near Ravindra Natya Grah, Opp. Central Mall, RNT Marg, Indore – Ph-6453856 54 Novo Nordisk India Private Limited, Plot No. 32, 47-50, EPIP Area, Whitefield, Bangalore-560066 55 Natco Pharma Limited Natco House, Road No.2, Banjara Hill, Hyderabad (A.P.) 500033 56 Parenteral Drugs (India) Limited, Shree Ganesh Chambers, A.B.Road, Navlakha Crossing, Indore-452001 57 Pfizer limited, Pfizer center, 5, patel estate, S.V.Road, Jogeshwari West, Mumbai-400102 58 Panacia Biotec limited, (1) B-1 Extn / A-27, Mohan Co-op Indl. Estate, Mathura Road, New Delhi-110044. (2) 16/5, street No. 3 , old Palasia, Near Samyak Tower, Indore-452001 59 Abbott Healthcare Limited ( formerly as Piramal Healthcare Limited ) Corresp.Add. - Near Parijat Castle, Guru Ghasidas Nagar, Ring Road No. 2, Bilaspur (C.G.) 495001 Fax : 07752-428825 MB Office : D Mart Bldg. Goregaon Mulund Link Road, Mulund (W) Mumbai- 400080 60 RPG Life Sciences Limited Ceal Mahal, 463, Dr.A.B.Road, Worli, Mumbai -400030 61 Ranbaxy Laboratories Limited, Western Edge- I, Unit No. 201- 204, 2nd floor, Western Express Highway, Borivali (E), Mumbai - 400066 Old Add. - H.M.T.D. Textile Compound, Kurla-Andheri Road, Jarimari, Behind M.K.Bros Ind. Estate, Mumbai-72 62 Serum Institute Of India Limited, 501,5th floor, Dalamal Tower, 211, Nariman Point, Mumbai-400021 63 Sanjivani Parenteral Limited, 205-P.N.Kothari Industrial Estate, L.B.S.Marg, Bhandup (West), Mumbai-400078 64 Serdia Pharmaceuticals (India) Pvt. Ltd. Serdia House, Office Dr.S.S.Rao Road, (Behind Mahatma Gandhi Memorial Hospital), Parel, Mumbai-400012 65 Shanta Biotechnics Limited, Vasantha Chambers, 3rd & 4th floor, # 5-10-173, Fathe Maidan Road, Basher Bagh, Hyderabad-500004 (AP) 66 Span Diagnostics Limited, 173-B,New Industrial estate, Udhna, Surat-394210 67 Solvay Pharma India Ltd., (1) Suraj Parkash, 1st Floor,# 86, Shankar Ghanker Marg, Parbhadevi, Mumbai- 400018. OLD : (2) 271 Business Park, 6th Floor, Model Industrial Colony, Off.Aarey Road, Goregaon (E), Mumbai - 400063 68 Southern Petrochemical Industries Corporation. Ltd. Spic House No.88, Mount Road, Guindy, Chennai- 600032 69 Sun Pharmaceutical Industries Ltd. ACME Plaza, Opp. Sangam Cinema , Andheri-Kurla Road, Andheri (E), Mumbai – 400059 70 Shreya Life sciences Private Limited Shreya House, 301 / A, Pareira Hill Road, Andheri (E), Mumbai- 400099 71 Tablet (India) Limited, “JHAVER CENTRE” 72, Marshalls Road, Chennai-600008 72 Themis Medicare Limited, 11/12, Udyog Nagar, S.V.Road, Goregaon (W) Mumbai-400104 73 Torrent Pharmaceuticals Limited, Torrent House, Off Ashram Road, Ahmedabad-380009 74 Troikaa Pharmaceuticals Limited, Commerce House-1, Satya Marg, Bodakdev, Ahmedabad-380054 75 M/s. Transasia Bio- Medicals Ltd. Transasia House, 8 Chandivali Studio Road, Andheri (E) , Mumbai – 400072 76 United Biotech Private Limited, FC/B-1(Extn.), Mohan Co-operative Industrial Estate, Mathura road, New Delhi-44 77 B.S.D.Marg, Govandi Station Road, Govandi, Mumbai-400088 78 Unichem Laboratories Limited, Unichem Bhavan, Prabhat Estate, S.V.Road, Jogeshwari (West), Mumbai-400102 79 UCB India Private Limited, 504 Peninsula Towers, G.K.Marg, Lower Parel, Mumbai-400 013 80 M/s. Venus Remedies Limited, Corp. Office: 51-52, Industrial Area, Phase – I,Panchkula ( Hry) 134113 Regd. Office: SCO 857, Cabin No.10, 2nd Floor,NAC, Manimajra, Chandigarh (U.T.) 160101 81 VHB Life Sciences Limited 50-AB, Govt. Industrial Estate, Charkop Naka, Kandivali (W), Mumbai - 400067 82 Win Medicare Private Limited 1400, Hemkunt Tower, 98, Nehru Place, New Delhi - 110019 83 Wallace Pharma Pvt. Ltd. B-307/312, Floral Deck Plaza, Central MIDC, Andheri (East), Mumbai-93 84 Wockhardt Limited Wockhardt Towers, Bandra Kurla Complex, Bandra (E), Mumbai - 400051 .
Load more

Recommended publications
  • SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI Trading As ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP
    Trade Marks Journal No: 1836 , 12/02/2018 Class 5 SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI trading as ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP. COTTON GREEN RLY. STN. MUMBAI-400033. MANUFACTURE & MERCHANT INDIAN NATIONAL Used Since :31/01/2001 MUMBAI MEDICINAL PREPARATIONS. 537 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 SEPTIGARD 1741718 08/10/2008 INDERJIT SINGH trading as ;INDERJIT SINGH B-104 , SWASTHYA SINGH , NEW DELHI -92 MERCHANTS & MANUFACTUERERS Address for service in India/Agents address: MAHTTA & CO. 43 - B/3, MAHTTA HOUSE,UDHAM SINGH NAGAR, LUDHIANA - 141 001, (PUNJAB). Proposed to be Used DELHI MEDICINAL & PHARMACEUTICAL PREPARATIONS. 538 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 FAIR & BEAUTY 1803779 08/04/2009 GALPHA LABORATORIES LIMITED 221, Kanakia Zillion, E Wing Bandra Kurla Complex Annex LBS Marg & CST Road Junction Kurla West MUMBAI 400070 MANUFACTURERS AND MERCHANTS INDIAN NATIONAL Used Since :15/11/2007 MUMBAI PHARMACEUTICAL AND MEDICINAL PREPARATIONS AND SUBSTANCES 539 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 O-BAMA 1815900 08/05/2009 KREMOINT PHARMA PVT. LTD. 151/5, SHRI KRISHNA DARSHAN, GARODIA NAGAR, GHATKOPAR (E), BOMBAY-400 077. MANUFACTURERS AND MERCHANTS. A CORPORATE ENTITY INCORPORATED IN INDIA UNDER THE COMPANIES ACT 1956. Address for service in India/Attorney address: KRISLAW CONSULTANTS BUILDING NO.4, C/104, SHANKESHWAR PALMS, BEHIND MODEL SCHOOL, KUMBHARKHANPADA, SUBHASH ROAD, DOMBIVILI(W) 421202 Used Since :02/05/2009 MUMBAI PHARMACETICAL AND MEDICINAL PREPARATIONS. 540 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 AYUSHAKTI D-VYRO 1815928 08/05/2009 SMITA NARAM BUNGALOW NO.31, NEXT TO M.
    [Show full text]
  • [email protected] 742-43, Dwarkapuri, Indore(MP)
    Seed Association of M.P., Indore As on 09.07.2018 Sr. No. Name & Address of Firm Name of Proprietor Phone (O) Phone (R) Fax No. Mobile No. Email ID Abhi Seeds Vill-Padlya, PO-Chadoda 1 Teh Depalpur Dist. Indore Shri Pritam Dhakad 9977882642 [email protected] Aditya Biotech Seeds, 8770772080 2 742-43, Dwarkapuri, Indore(M.P.) Shri Pradeep Jain 0731-2786905 Shri Vikash Jain 8517801239 [email protected] Agrawal Enterprises Shri Bhagwan Sales Corporation, Chindwara Road, Seoni 07692-38413 [email protected] 3 Dist. Seoni(M.P.) Shri Krishna K. Agrawal 07692-38513 9993111639 9993584966 [email protected] Agrawal Seeds Centre Nemawar Main Road, Opp. Jain Mandir,Double Chowki, 4 Dist. Dewas Shri Amit Agrawal 0731-2866539 9425321270 [email protected] Ajeet Seeds Ltd. PU-3, Sch.No.54, 211,IInd Floor, 0731- Satguru Parinay, Near Pakiza 2553211 5 Show Room, A.B. Road, Indore Shri Ashok Shewale 0731-2554211 8889908010 [email protected] Amar Biotech Ltd., 6-2,913/914, IV Floor, Progressive Towers, 6 Khairatabad, Hydrabad (AP) Shri K.Narendra 7702770779 7702770779 [email protected] Ambrocia Seeds Producer Co.Ltd., MIG-36, Iind Floor, BDA Colony, 7 Manisha Market, Shahpura,Bhopal Shri Pawan Nagre 9165012555 0755-4904800 9165012555 [email protected] Amit Seeds 148 Vidya Nagar, 9425928591 8 B/H Sapna Sangita Talkies, Indore Shri Santosh Agrawal 0731-2223991 0731-2461473 9926085005 [email protected] Anand Biotech, A-48-49, Sudama Nagar, Near Arti Devi School, 9 Indore(M.P.) Shri Rajendra Gupta 9425057161 9425057161 [email protected] Anjani Seeds, Bhawani Mata Road, [email protected] 10 Khandwa (M.P.) Shri Shishir Gupta 0733-2244000 9425085454 [email protected] Ankur Seeds Pvt.
    [Show full text]
  • Ajanta Pharma Limited
    AJANTA PHARMA LIMITED CIN : L24230MH1979PLC022059 Registered & Corporate Office: ‘Ajanta House’, 98 Govt Industrial Area, Charkop, Kandivli (West), Mumbai - 400 067, Maharashtra, India Tel.: +91 22 6606 1000, Fax: +91 22 6606 1200 | E-mail: [email protected] | Website: www.ajantapharma.com POST BUYBACK PUBLIC ANNOUNCEMENT FOR THE ATTENTION OF EQUITY SHAREHOLDERS/ BENEFICIAL OWNERS OF EQUITY SHARES OF AJANTA PHARMA LIMITED This public announcement (the “Post Buyback Public Announcement”) is being made pursuant to the provisions of Regulation 24(vi) of the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, for the time being in force including any statutory modifications and amendments from time to time (the “Buyback Regulations”). This Post Buyback Public Announcement should be read in conjunction with the Public Announcement dated November 4, 2020 which was published on November 5, 2020 (the “Public Announcement”) and the letter of offer dated November 25, 2020 (the “Letter of Offer”) issued in connection with the Buyback. The terms used but not defined in this Post Buyback Public Announcement shall have the same meanings as assigned in the Public Announcement and the Letter of Offer. 1. THE BUYBACK 1.1 Ajanta Pharma Limited (the “Company”) had announced the Buyback of not exceeding 7,35,000 (Seven Lakh Thirty Five Thousand) fully paid-up equity shares of face value of ₹2 each (“Equity Shares”) from all the existing shareholders / beneficial owners of Equity Shares as on the record date (i.e. Friday, November 13, 2020), on a proportionate basis, through the “Tender Offer” process at a price of ₹1,850/- (Rupees One Thousand Eight Hundred and Fifty Only) per Equity Share payable in cash for an aggregate consideration not exceeding ₹ 135,97,50,000 (Rupees One Hundred Thirty Five Crores Ninety Seven Lakhs and Fifty Thousand only) excluding the Transaction Costs (“Buyback Offer Size”).
    [Show full text]
  • Inner 25 India Pharma & Healthcare Fund
    Modera erate tely Mod High to e H w at ig o er h L d o M V e r y w H Tata India Pharma & Healthcare Fund o i L g (An open ended equity scheme investing in Pharma and Healthcare Services Sector) h Riskometer Investors understand that their principal As on 30th June 2021 PORTFOLIO will be at Very High Risk INVESTMENT STYLE Company name No. of Market Value % of Company name No. of Market Value % of Primarily focuses on investment in at least 80% of its net Shares Rs. Lakhs Assets Shares Rs. Lakhs Assets assets in equity/equity related instruments of the companies in the Pharma & Healthcare sectors in India. Equity & Equity Related Total 55184.24 97.88 Glenmark Pharmaceuticals Ltd. 167000 1089.76 1.93 INVESTMENT OBJECTIVE Healthcare Services Sanofi India Ltd. 13000 997.39 1.77 The investment objective of the scheme is to seek long Apollo Hospitals Enterprise Ltd. 70500 2551.99 4.53 Gland Pharma Ltd. 19662 673.29 1.19 term capital appreciation by investing atleast 80% of its Fortis Healthcare Ltd. 795000 1935.03 3.43 Laurus Labs Ltd. 90000 619.79 1.10 net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in Syngene International Ltd. 265000 1545.75 2.74 India.However, there is no assurance or guarantee that the investment objective of the Scheme will be Narayana Hrudayalaya Ltd. 301420 1483.74 2.63 Other Equities^ 1186.14 2.10 achieved.The Scheme does not assure or guarantee any Metropolis Healthcare Ltd.
    [Show full text]
  • MF 35 Fund One Pager
    BR“BuyS RightT : BSit TightR” ST BRSnowT Bin fourRS differentTBRS colorsTBRS BRSTBRSTBRSTBR Motilal Oswal MOSt Focused Invests in enduring B25 RFund STBRSTBwRealth creaStors T Motilal Oswal MOSt Focused Invests in emerging BMidcapR 30 Fund TBRwealth creators T BRSTBSRSTBRSTBSRS Motilal Oswal MOSt Focused Invests in emerging and BMulticapRS 35 FundT BRSTBRenduringST wealthB creatorRs Lock in fund that invests Motilal Oswal MOSt Focused in wealth creators BLongR Term SFund TBRSTBplusR Saves TSax T BR TBR T BRSTBSRSTBRSTBSRS Focused Low Churn QGLP No load BRSTBPortfolioRSTBPortfolioRSTStocksBR BRSInvesTt nowB to addR colorSs Tto yourB porRolioST BRSCall:T 1800-200-6626B | SMS:R FOCUSS to 575753T BRSTBRS Website: www.motilaloswalmf.com Our Investment Philosophy The recommended way to create Wealth from equity- 'Buy Right : Sit Tight' At Molal Oswal Asset Management Company (MOAMC), our investment philosophy and invesng style is centered on 'Buy Right: Sit Tight‘ principal. ‘Buy Right' means buying quality companies at a reasonable price and 'Sit Tight' means staying invested in them for a longer me to realise the full growth potenal of the stocks. Buy Right Stock Characteristics Sit Tight Approach QGLP ‘Q’uality denotes quality of the business and Buy and Hold: We are strictly buy and hold management investors and believe that picking the right ‘G’rowth denotes growth in earnings and business needs skill and holding onto these sustained RoE businesses to enable our investors to benefit from the entire growth cycle needs even more ‘L’ongevity denotes longevity of the skill. competitive advantage or economic moat of the business Focus: Our portfolios are high conviction portfolios with 20 to 25 stocks being our ideal ‘P’rice denotes our approach of buying a good n u m b e r.
    [Show full text]
  • CARE Ratings Ltd
    CARE/HO/RL/2020-21/2749 Mr. Arvind Agrawal Chief Financial Officer Ajanta Pharma Limited Ajanta House, Charkop, Kandivali (W), Mumbai-400067 October 1, 2020 Confidential Dear Sir, Credit rating for bank facilities On the basis of recent developments including operational and financial performance of your company for FY20 (audited) and Q1FY21 (provisional), our Rating Committee has reviewed the following ratings: Facilities Amount Rating1 Rating (Rs. crore) Action Long-term/Short-term Bank 55.00 CARE AA; Stable/CARE A1+ Facilities (reduced from 87.50) (Double A; Outlook: Stable/A Reaffirmed One Plus) Total 55.00 (Rs. Fifty Five crore only) 2. Refer Annexure 1 for details of rated facilities. 3. The rationale for the rating will be communicated to you separately. A write-up (press release) on the above rating is proposed to be issued to the press shortly, a draft of which is enclosed for your perusal as Annexure-2. We request you to peruse the annexed document and offer your comments if any. We are doing this as a matter of courtesy to our clients and with a view to ensure that no factual inaccuracies have inadvertently crept in. Kindly revert as early as possible. In any case, if we do not hear from you by October 5, 2020 we will proceed on the basis that you have no any comments to offer. 4. CARE reserves the right to undertake a surveillance/review of the rating from time to time, based on circumstances warranting such review, subject to at least one such review/surveillance every year. 5.
    [Show full text]
  • Sr. No. Name Status Class Business Activity Address Contact Number
    Authorize Paid-up Registration Sr. No. Name Status Class Business Activity Address Contact Number Email ID - I Email ID - II Website Remark Links Category CIN No State District Pin Code Capital Capital Date 2 21ST CENTURY PROFESSIONALS PRIVATE LIMITED ACTIVE Private Business Services 4TH FLOOR,C21 MALL, PLOT NO 94 to 104 & 300 to 303 PU - 4, SCHEME NO. 54, A.B. ROAD, INDORE Madhya Pradesh INDIA 452010 Contact Details Not Available Company Limited by Shares 100000 100000 08/02/88 U74140MP1988PTC004379 Madhya pradesh Indore 452010 4 3G INFOTECH PRIVATE LIMITED ACTIVE Private Business Services 21/2, Race Course Road, Indore Madhya Pradesh INDIA 452001 http://3ginfotech.com/ Company Limited by Shares 100000 100000 06/02/09 U72200MP2009PTC021604 Madhya pradesh Indore 452001 8 6 DEGREES IT PRIVATE LIMITED ACTIVE Private Business Services 9/2, STREET NO.5, MANORAMAGANJ INDORE Madhya Pradesh INDIA 452001 Company Limited by Shares 500000 100000 10/02/10 U72200MP2010PTC023064 Madhya pradesh Indore 452001 16 A TO Z ONLINE BOUTIQUE PRIVATE LIMITED ACTIVE Private Business Services EC-2 SCH NO-94 UG-1 AMAR POINT BOMBAY HOSPITAL SQUARE INDORE Madhya Pradesh INDIA 452001 Contact Details Not Available Company Limited by Shares 1000000 660000 26/02/08 U74994MP2008PTC020384 Madhya pradesh Indore 452001 26 A.V. BIO-ENERGY PRIVATE LIMITED ACTIVE Private Business Services 21-MARTOND CHOWK NEAR RAMBAGH SQUARE INDORE Madhya Pradesh INDIA 452001 [email protected] [email protected] Company Limited by Shares 3000000 3000000 06/04/10 U74999MP2010PTC023332 Madhya pradesh Indore 452001 29 A2Z MANPOWER SERVICES PRIVATE LIMITED ACTIVE Private Business Services 173-D, SLICE NO.
    [Show full text]
  • Indore Road 17850 26780 17850 24850 23850 21850 20850 37000 36500 36000 0 0 10500000 10500000 17850 26780
    GUIDELINE Madhya Pradesh Government PLOT (SQM) BUILDING RESIDENTIAL (SQM) BUILDING COMMERCIAL (SQM) BUILDING MULTI (SQM) Agriculture land Plot (HECTARE/SQM) S.No Mohalla/Colony/ Society/Road/Village Sub Clause Sub Clause Kaccha Residential Commercial Industrial RCC RBC Tin shade Shop Office Godown Residential Commercial Irrigated Un irrigated wise wise kabelu Residential Commercial (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) Tehsil: DEPALPUR Sub-Area : NAGAR PANCHAYAT BETMA, Ward/Patwari Halka: WARD NO 1 1 BHEEL BAKHAL 7000 10500 7000 14000 13000 11000 10000 22000 21500 21000 0 0 10500000 10500000 7000 10500 2 DEPALPUR ROAD 12000 18000 12000 19000 18000 16000 15000 29500 29000 28500 0 0 10500000 10500000 12000 18000 3 DHAR ROAD 17850 26780 17850 24850 23850 21850 20850 37000 36500 36000 0 0 10500000 10500000 17850 17850 4 GURUKRAPA COLONY 10000 15000 10000 17000 16000 14000 13000 26500 26000 25500 0 0 100000000 100000000 10000 15000 5 HOSPITAL KE PEECHE 10000 15000 10000 17000 16000 14000 13000 26500 26000 25500 0 0 10500000 10500000 10000 15000 6 INDORE ROAD 17850 26780 17850 24850 23850 21850 20850 37000 36500 36000 0 0 10500000 10500000 17850 26780 7 MANTRI NAGAR 10000 15000 10000 17000 16000 14000 13000 26500 26000 25500 0 0 100000000 100000000 10000 15000 Financial Year: 2018-2019 Name of District: INDORE Page 1 of526 BUILDING MULTI PLOT (SQM) BUILDING RESIDENTIAL (SQM) BUILDING COMMERCIAL (SQM) Agriculture land Plot (HECTARE/SQM) (SQM) S.No Mohalla/Colony/ Society/Road/Village Sub Clause Sub
    [Show full text]
  • PUBLIC ANNOUNCEMENT for the ATTENTION of EQUITY SHAREHOLDERS/ BENEFICIAL OWNERS of As Partner of Ganga Exports, Where the Partner’S Share Being 37.5%
    ii. Shareholding of directors of the Promoters and Promoter Group entity (i.e. Gabs Investment Private Limited ii. the amount of permissible capital payment (including premium) as stated in Annexure A for the proposed (“GIPL”)) in the Company: buy-back of equity shares has been properly determined considering the audited standalone financial statements and audited consolidated financial statements in accordance with Section 68(2) of the Act; and Sr. Designation No. of Equity Shares held Percentage (%) of issued Name iii. the Board of Directors of the Company in their meeting dated 3 November 2020, have formed the opinion No. in GIPL in the Company Equity Share capital as specified in clause (x) of Schedule I to the SEBI Buy-back Regulations on reasonable grounds and 1. Yogesh Agrawal Director 1,35,36,523(1) 15.51 that the Company will not, having regard to its state of affairs, be rendered insolvent within a period AJANTA PHARMA LIMITED 2. Rajesh Agrawal Director 1,35,36,522(2) 15.51 of one year from that date. CIN : L24230MH1979PLC022059 3. Ravi Agrawal Director 1,33,32,906(3) 15.28 Auditors’ Responsibility (Continued) Registered & Corporate Office: ‘Ajanta House’, 98 Govt Industrial Area, Charkop, 4. Aayush Agrawal Director 1,25,60,389(4) 14.39 5. The audited standalone financial statements and audited consolidated financial statements referred to in Kandivli (West), Mumbai - 400 067, Maharashtra, India Total 5,29,66,340 60.69 paragraph 5 above, which we have considered for the purpose of this report, have been audited by us, on Tel.: +91 22 6606 1000, Fax: +91 22 6606 1200 | E-mail: [email protected] which we have issued an unmodified audit opinion vide our reports dated 20 May 2020.
    [Show full text]
  • Defying Challenges Achieving Growth
    Annual Report 2019-20 Resilience Defying Achieving Challenges Growth What’s Inside Corporate Overview Statutory Reports Financial Statements 0 2 Letter to Shareholder 15 Management Discussion and 56 Consolidated Analysis 0 4 Business Overview 124 Standalone 20 Directors’ Report 0 6 Resilience: Defying Challenges 190 Notice / Achieving Growth 40 Report on Corporate Governance 10 Resilient Infrastructure 12 Financial Overview 14 Corporate Information For additional information scan the QR CODE For more details, please visit: www.ajantapharma.com Resilienceliterally means ‘capacity to recover quickly from difficulties’. We at Ajanta Pharma, have shown this ability time and again: Defying Challenges faced on the way and Achieving Growth. Each challenge brings associated risks with it, but our proactive approach allows us to defy it so that we continue the growth even during that time. New manufacturing facility for oral solid inaugurated at Pithampur The following pages detail such efforts, which allow us to de-risk the business in a way that insulates it from macro concerns to the extent possible. It is these efforts that make us resilient. Letter to Shareholder DESPITE THE CAPEX OF K 240 CR. IN FY 2020 WE GENERATED OPERATING FREE CASH FLOW OF K 235 CR. IN THE YEAR. Yogesh M. Agrawal Managing Director Dear Shareholder, We hope and wish that all of you have been safe and differentiated products along with seamless execution healthy during this unprecedented challenge faced by allow us to delight our customers, which in turn the humanity. The uncertainty around the course of generates superior quality business for us. This year the COVID-19 pandemic started in March leading to was no exception as it reconfirmed our capability to governments across the world initiating lockdowns.
    [Show full text]
  • List of Nodal Officer
    List of Nodal Officer Designa S.No tion of Phone (With Company Name EMAIL_ID_COMPANY FIRST_NAME MIDDLE_NAME LAST_NAME Line I Line II CITY PIN Code EMAIL_ID . Nodal STD/ISD) Officer 1 VIPUL LIMITED [email protected] PUNIT BERIWALA DIRT Vipul TechSquare, Golf Course Road, Sector-43, Gurgaon 122009 01244065500 [email protected] 2 ORIENT PAPER AND INDUSTRIES LTD. [email protected] RAM PRASAD DUTTA CSEC BIRLA BUILDING, 9TH FLOOR, 9/1, R. N. MUKHERJEE ROAD KOLKATA 700001 03340823700 [email protected] COAL INDIA LIMITED, Coal Bhawan, AF-III, 3rd Floor CORE-2,Action Area-1A, 3 COAL INDIA LTD GOVT OF INDIA UNDERTAKING [email protected] MAHADEVAN VISWANATHAN CSEC Rajarhat, Kolkata 700156 03323246526 [email protected] PREMISES NO-04-MAR New Town, MULTI COMMODITY EXCHANGE OF INDIA Exchange Square, Suren Road, 4 [email protected] AJAY PURI CSEC Multi Commodity Exchange of India Limited Mumbai 400093 0226718888 [email protected] LIMITED Chakala, Andheri (East), 5 ECOPLAST LIMITED [email protected] Antony Pius Alapat CSEC Ecoplast Ltd.,4 Magan Mahal 215, Sir M.V. Road, Andheri (E) Mumbai 400069 02226833452 [email protected] 6 ECOPLAST LIMITED [email protected] Antony Pius Alapat CSEC Ecoplast Ltd.,4 Magan Mahal 215, Sir M.V. Road, Andheri (E) Mumbai 400069 02226833452 [email protected] 7 NECTAR LIFE SCIENCES LIMITED [email protected] SUKRITI SAINI CSEC NECTAR LIFESCIENCES LIMITED SCO 38-39, SECTOR 9-D CHANDIGARH 160009 01723047759 [email protected] 8 ECOPLAST LIMITED [email protected] Antony Pius Alapat CSEC Ecoplast Ltd.,4 Magan Mahal 215, Sir M.V. Road, Andheri (E) Mumbai 400069 02226833452 [email protected] 9 SMIFS CAPITAL MARKETS LTD.
    [Show full text]
  • Route Map for Indore Metro
    LINE 1 CH 0 + 000.000 SRI ARBINDO HOSPITAL BHAWARSALA SQUARE SUPER CORRIDOR 1 2 3 + 0 LINE 2 0 1 CH 5 0 0 .8 + 00 1 0.0 9 00 7 2 + 4 3 + 2 0 1 H 0 5 .8 C 0 1 2 2 0 DEWAS NAKA + 4 2 2 + H MR 10 ROAD 0 C 0 SUPER CORRIDOR 2 0 C H 2 1 + C 36 H 1 .8 2 5 2 LINE 4 1 1 2 + 5 + 1 15 + 1. 0 8 0 5 1 0 1 0 5 0 .8 SANWER 1 0 8 0 CH + 0 5 + 2 00 INDUSTRIAL AREA 0.0 MR 9 SUPER CORRIDOR 3 H 00 C 1 5 .8 1 5 4 ISBT / MR 10 FLYOVER + 5 2 H C 2 LAHIYA COLONY 0 NIRANJANPUR CIRCLE + 2 6 0 + 0 0 0 0 0 SUPER CORRIDOR 4 CONVENTION CENTER 19 +0 0 2 0 7 + ARANYA NAGAR 0 0 CHANDRAGUPTA SQARE0 GANESH SHAM COLONY HIRA NAGAR 2 8 + 0 0 1 0 8+ 00 SUPER CORRIDOR 5 0 SUKLIYA BAPAT SQUARE IDA PARK MEGHDHOOT GARDEN 2 9 + VIJAY NAGAR SQUARE BANGANGA 0 0 3 17 0 + 0 0 0 0 0 0 + 0 . 0 5 0 9 + 0 0 0 3 0 0 4 . 0 1 H 3 2 + C + 0 5 NANDA NAGAR 0 H SUPER CORRIDOR 6 0 MAIN ROAD C LAXMIBAI NAGAR SQUARE RADISON SQUARE BHAMORI 16 0 C 0 0 + + H 2 T 0 3 0 6 + 0 57 O 0.0 MAZDOOR 00 P PATNI PURA / E MAIDAN LINE 3 D ST JOSEPH CHURCH MUMTAJ BAG COLONY 0 CH 6 + 840.00 C CH 6 + H 15 900.000 + 36 1.852 00 CH 0 MARI MATA SQUARE +15 + 0 15 81.852 0.000 CH 7 + 20 MALWA MILL 3 3 + 0 0 SQUARE 0 LINE 3S 2 5 C 2 GHANDI NAGAR / 8 H .
    [Show full text]